Recruiting OBSERVATIONAL NCT05017766

NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria (AntiResist)

NCCR AntiResist: Mono-center Study to Identify New Approaches to Combat Antibiotic-resistant Bacteria.

Sponsor: Swiss National Science Foundation

Conditions Antimicrobial Resistance (AMR)

Interventions analysis of antimicrobial resistance

Updated 6 times since 2021 Last updated: Feb 27, 2025 Started: Dec 3, 2020 Primary completion: Dec 31, 2028 Completion: Dec 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05017766, this observational or N/A phase trial focuses on Antimicrobial Resistance (AMR) and remains actively recruiting participants. Sponsored by Swiss National Science Foundation, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Apr 2025 — Present [monthly]

Recruiting
Sep 2024 — Apr 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2024 — Jul 2024 [monthly]

Recruiting
Dec 2021 — Mar 2024 [monthly]

Recruiting

▶ Show 1 earlier version

Sep 2021 — Dec 2021 [monthly]

Recruiting

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Swiss National Science Foundation
University Hospital, Basel, Switzerland

Data source: University Hospital, Basel, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland